SCHEMBL6765535

SCHEMBL6765535

CC(C)COC(=O)N[C@@H](CC(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
CTSK P43235 4/20 0.41
CTSS P25774 3/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
PPARA Q07869 5/20 0.39
PPARG P37231 4/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
CAPN1 P07384 1/20 0.36
ACE P12821 1/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21446926 0.88 CTSK (0.47) CYP2D6CTSKCTSSCTSLCTSB
SCHEMBL6701850 0.86 FOLH1 (0.44) CYP2D6SMN1; SMN2CTSKCTSSCTSL
SCHEMBL343678 0.84 CYP2D6 (0.55) CYP2D6CTSKCTSSCTSLCTSB
SCHEMBL343679 0.84 CYP2D6 (0.55) CYP2D6CTSKCTSSCTSLCTSB
SCHEMBL3682214 0.84 CYP2D6 (0.55) CYP2D6CTSKCTSSCTSLCTSB
SCHEMBL6763914 0.81 SMN1; SMN2 (0.53) SMN1; SMN2CA2ITGB3ITGAV
SCHEMBL14542733 0.80 GRN (0.49) SMN1; SMN2CTSKCTSSCTSLCTSB
SCHEMBL12513814 0.80 GRN (0.49) SMN1; SMN2CTSKCTSSCTSLCTSB
SCHEMBL5832014 0.80 SMN1; SMN2 (0.49) CYP2D6SMN1; SMN2HDAC3HDAC1HDAC2
SCHEMBL4364211 0.80 CTSK (0.45) CYP2D6CTSKCTSSCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723710-B2 BORON GROUP-SUBSTITUTED ACYCLIC ALPHA AMINO ACIDS ARE USEFUL FOR INHIBITING A VARIETY OF ARINASE- AND NO SYNTHASE-RELATED DISORDERS, INCLUDING HEART DISEASE, GASTROINTESTINAL MOTILITY DISORDERS, AND PENILE ERECTILE DYSFUNCTION IN HUMANS. THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2004-04-20 US disclosed
US-20030036529-A1 Compositions and methods for inhibiting arginase activity THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2003-02-20 US disclosed
US-6387890-B1 CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS; SEXUAL DISORDERS TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2002-05-14 US disclosed
EP-1049660-A1 COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2000-11-08 EP disclosed
WO-1999019295-A1 COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1999-04-22 WO disclosed